Retarded mound healing was found in mice deficient in the serine protease p
recursor plasminogen, as well as in wild-type mice treated with the metallo
protease inhibitor galardin, but in both cases wound closure was ultimately
completed in all mice within 60 days. The expression of several matrix met
alloproteases in keratinocytes migrating to cover the wound was strongly en
hanced by galardin treatment, However, when plasminogen-deficient mice were
treated with galardin, healing was completely arrested and mound closure w
as not seen during an observation period of 100 days, demonstrating that pr
otease activity is essential for skin wound healing. The requirement for bo
th plasminogen deficiency and metalloprotease inhibition for complete inhib
ition of the healing process indicates that there is a functional overlap b
etween the two classes of matrix-degrading proteases, probably in the disse
ction of the fibrin-rich provisional matrix by migrating keratinocytes, Eac
h class alone is capable of maintaining sufficient keratinocyte migration t
o regenerate the epidermal surface, although this function mould normally b
e performed by both classes acting in parallel. Since there are strong simi
larities between the proteolytic mechanisms in wound healing and cancer inv
asion, these results predict that complete arrest of this latter process in
therapeutic settings will require the use of inhibitors of both classes of
proteases.